Silhouette

ROBERT DAVID STEINER

Circumvent Pharmaceuticals, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Development of N-tert-(Butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating Infantile ...
Circumvent Pharmaceuticals, Inc.
Principal Investigator
HHS 1 $199K 03/01/17 11/30/17